AKASH KHANDELWAL,ISABELLE DUSSAULT,SAMER EL BAWAB,YULIA VUGMEYSTER
申请号：
BR112019013924
公开号：
BR112019013924A2
申请日:
2018.01.05
申请国别(地区):
BR
年份:
2020
代理人:
摘要：
the present invention relates in general to bw-independent dosing regimens and dosage forms of a bifunctional protein targeting the programmed cell death binding human protein 1 (pd-l1) and the factor transforming growth factor (tgfß).a presente invenção refere-se de modo geral a regimes de dosagem independente do peso corporal (bw-independent) e formas de dosagem de uma proteína bifuncional tendo por alvo a proteína humana ligante de morte celular programada 1 (pd-l1) e o fator de crescimento transformante ß (tgfß).
